Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus conference on Pain in Neurorehabilitation.
Olfactory dysfunction as a marker of multiple sclerosis progression.
MHC-I and PirB Upregulation in the Central and Peripheral Nervous System following Sciatic Nerve Injury.
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives.
Optic neuropathy associated with systemic sarcoidosis.
Phosphorylated TandeMBP: A unique protein substrate for protein phosphatase assay.
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.
Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFα in vitro.
Contribution of EAE to understanding and treating multiple sclerosis.
Nonlinear associations between human values and neuroanatomy.
Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.
Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
Comparison of serum Concentration of Se, Pb, Mg, Cu, Zn, between MS patients and healthy controls.
Predictors of the 10-year direct costs for treating multiple sclerosis.
Fatigue and gait speed in multiple sclerosis: Assessment and relationship.
Differences in iron and manganese concentration may confound the measurement of myelin from R1 and R2 relaxation rates in studies of dysmyelination.
Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
[Effect of axonal developmental disorders in the corpus callosum on the neurological function after birth in septic neonatal rats].
Interferons and inflammasomes: Cooperation and counterregulation in disease.
Immunoadsorption in patients with neuromyelitis optica spectrum disorder.
Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders.
Pages
« first
‹ previous
…
786
787
788
789
790
791
792
793
794
…
next ›
last »